Transcatheter Mitral Valve Replacement (TMVR) Market Research and Clinical Analysis 2021 to 2026

The report titled “Transcatheter Mitral Valve Replacement (TMVR) Market” has recently added by MarketInsightsReports to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts.

The next five years the Transcatheter Mitral Valve Replacement (TMVR) market will register a 28.7% CAGR in terms of revenue, the global market size will reach US$ 2435.3 million by 2026.

 Get a Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/03252755516/global-transcatheter-mitral-valve-replacement-tmvr-market-growth-status-and-outlook-2021-2026/inquiry?mode=74       

Key Market Players:

Abbott, Edwards Lifesciences, Medtronic, Boston Scientific, Micro Interventional Devices, Neovasc, LivaNova, HighLife SASand Other

Executive Summary

The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time.

The causes of MR disease are congenital heart disorder, rheumatic fever, trauma, any other heart disease, radiation therapy, etc. The treatments available for MR disease are surgical repair, drug treatment and replacement. There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The DMR and FMR can further be subdivided into many types.

There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years.

Industry News

Sept. 21, 2020: Abbott (NYSE: ABT) today announced it has received CE Mark for its fourth-generation MitraClip™ Transcatheter Mitral Valve Repair System, the leading minimally invasive mitral valve repair device in the world. Known as MitraClip G4, the device is now approved for use in Europe and other countries that recognize CE Mark as a non-surgical option for the treatment of mitral regurgitation (MR), or a leaky heart valve. The device is already approved for use in the U.S.

Sept. 27, 2019 :Medtronic plc (NYSE:MDT) today reported it has gotten U.S. Food and Drug Administration (FDA) endorsement to start an early practicality study (EFS) for its Intrepid™ transcatheter mitral valve substitution (TMVR) framework utilizing a negligibly intrusive transfemoral access approach. This declaration expands upon essential endpoint results of the Intrepid TMVR pilot study utilizing the transapical approach distributed in the Journal of the American College of Cardiology, the first-since forever preliminary supported by the FDA to assess the security and viability of a TMVR framework.

Market Segmentation by Types:

MitraClip
Edwards PASCAL
Edwards SAPIEN 3

Market Segmentation by Applications:

Functional Mitral Regurgitation (FMR)
Degenerative Mitral Regurgitation (DMR)

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Explore Full Report With Detailed TOC Here:

https://www.marketinsightsreports.com/reports/03252755516/global-transcatheter-mitral-valve-replacement-tmvr-market-growth-status-and-outlook-2021-2026?mode=74      

The market factors explained in the report:

Market Overview: It includes Transcatheter Mitral Valve Replacement (TMVR) Market study scope, top key players, segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: The Transcatheter Mitral Valve Replacement (TMVR) Market report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Regional Study: All of the regions and countries analyzed in the Transcatheter Mitral Valve Replacement (TMVR) Market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Key Players: This part of the Transcatheter Mitral Valve Replacement (TMVR) Market report discusses expansion plans of companies, key mergers and acquisitions, funding and investment analysis, company establishment dates, revenues of manufacturers, and their areas served and manufacturing bases.

Market Forecast: Here, the report offers a complete forecast of the global Transcatheter Mitral Valve Replacement (TMVR) Market by product, application, and region. It also offers global sales and revenue forecasts for all years of the forecast period.

Note: All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply-chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

We Offer Customization on Report Based on Specific Client Requirement:
–country Level analysis for any 5 countries of your choice.
–Competitive analysis of any 5 key market players.
–40 analyst hours to cover any other data point.

Contact Us:

IrfanTamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

sales@marketinsightsreports.com  | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.